Blog

In every news cycle, there’s at least one story about GLP-1 drugs such as Ozempic, Wegovy and Zepbound. Although some extol the drugs’ health benefits, most focus on economics, including the drugs’ high cost, the growing reluctance of private and public insurance plans to cover the expense and the resulting affordability crisis for patients. With a dose of common sense, we can solve…

A recent study published in the journal Nature Communicationsexamined an understudied group of coronaviruses known as merbecoviruses — the same viral subgenus that includes MERS-CoV — to better understand how they infect host cells. The research…

In a new study published in the scientific journal Nature, the researchers demonstrate how this new technology can instantaneously translate brain activity into voice as a person tries to speak — effectively creating a digital vocal tract.

The system allowed the…

Now Tufts researchers led by Krishna Kumar, Robinson Professor of Chemistry, have designed a…

Lumeris announced today that it will be partnering with Google Cloud to build and advance a cutting-edge primary-care-as-a-service platform. Specifically, Lumeris’ Tom platform will leverage Google Cloud’s AI models and infrastructure to embed directly within primary care workflows in order to independently assess and execute the next best action for patients, including: automatically checking in on high risk patients…